Análisis jurídico del sistema de alertas para el control de la calidad de los medicamentos de la subasta inversa de medicamentos establecido por el Servicio Nacional de Contratación Pública

Abstract

Abstract:The medicines corporate purchase is the most significant mechanism, in quantity terms, of drug supply to the public health network, and is carried out through corporate reverse auctions administered by the National Public Procurement Service, who allow framework agreements are signed giving origin to the medicines electronic catalog, through this the state entities acquire these properties directly. In 2016, the National Public Procurement Service issued Resolution RE-SERCOP-2016- 000072, through this instituted a quality control procedure for the medicines subject to the framework agreements, avoiding the constitutional competence of the national health authority, the Public Health Ministry, to exercise the rectory, formulate the national health policy and control health-related activities. This work constitutes a descriptive and comparative study of the medicines systems quality control, established by the National Agency of Regulation, Control and Sanitary Vigilance, executing arm of the Public Ministry Health, and of the National Public Procurement Service and an analysis of validity of the normative act issued by the same, to establish its legal effectiveness.